SDOS查詢結果

類型

語文

總筆數:7

篇名作者刊名出版年查看
Anticholinergic side effects with long-term transdermal oxybutynin foroveractive bladder symptoms* Davila, G.W.;Dmochowski, R.R.;Sanders, S.W.; Obstetrics and Gynecology 2002-04-01 查看
Does hormone replacement affect overactive bladder symptoms and quality oflife during transdermal oxybutynin therapy?* Davila, G.W.;Dmochowski, R.R.;Sanders, S.W.; Obstetrics and Gynecology 2002-04-01 查看
Influence of age on improvement in overactive bladder symptoms and adverseevents during transdermal oxybutynin treatment* Davila, G.W.;Dmochowski, R.R.;Sanders, S.W.; Obstetrics and Gynecology 2002-04-01 查看
Transdermal delivery of oxybutynin: efficacy and tolerability in women withoveractive bladder Davila, G.W.;Dmochowski, R.R.;Sand, P.K.;for The Transdermal Oxybutynin Study Group; Obstetrics and Gynecology 2003-04-01 查看
Extended-release formulations of oxybutynin and tolterodine exhibitsimilar central nervous system tolerability profiles: A subanalysis of datafrom the OPERA trial Chu, F.M.;Dmochowski, R.R.;Lama, D.J.;Anderson, R.U.;Sand, P.K.; American Journal of Obstetrics and Gynecology 2005-06-01 查看
The impact of the overactive bladder syndrome on sexual function: Apreliminary report from the Multicenter Assessment of Transdermal Therapyin Overactive Bladder with Oxybutynin trial Sand, P.K.;Goldberg, R.P.;Dmochowski, R.R.;McIlwain, M.;Dahl, N.V.; American Journal of Obstetrics and Gynecology 2006-12-01 查看
The impact of the overactive bladder syndrome on sexual function: Apreliminary report from the Multicenter Assessment of Transdermal Therapyin Overactive Bladder with Oxybutynin trial Sand, P.K.;Goldberg, R.P.;Dmochowski, R.R.;McIlwain, M.;Dahl, N.V.; American Journal of Obstetrics and Gynecology 2006-12-01 查看
上一頁 第1頁/共1頁/跳至 下一頁